Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy

Withdrawn before enrolling · Phase 4

Conditions studied: Exudative Age Related Macular Degeneration

In brief

Optical Coherent Tomography Angiography (OCTA)-Directed PDT Triple Therapy for Treatment-Naïve Patients with Exudative Age-related Macular Degeneration (ARMD) versus Standard of Care Anti-VEGF Monotherapy

Key facts

Study ID
NCT04075136
Run by
Wake Forest University Health Sciences
People needed
0
Starts
2023-03-30
Expected to finish
2024-12-01
Last updated by the study team
2024-03-22

Who can join

Age: 50 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.